Inventory Summary of Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp.'s latest annual inventory in 2023 was -6970.00 CAD , down 0.0% from previous year.
Nova Mentis Life Science Corp.'s latest quarterly inventory in 2024 Q2 was -4061.00 CAD , up 100.0% from previous quarter.
Nova Mentis Life Science Corp. reported annual inventory of - CAD in 2022, down 0.0% from previous year.
Nova Mentis Life Science Corp. reported annual inventory of - CAD in 2021, down -100.0% from previous year.
Nova Mentis Life Science Corp. reported quarterly inventory of -4061.00 CAD for 2024 Q2, up 100.0% from previous quarter.
Nova Mentis Life Science Corp. reported quarterly inventory of - CAD for 2023 FY, down 0.0% from previous quarter.

Annual Inventory Chart of Nova Mentis Life Science Corp. (2023 - 2005)

Historical Annual Inventory of Nova Mentis Life Science Corp. (2023 - 2005)

Year	Inventory	Inventory Growth
2023	-6970.00 CAD	0.0%
2022	- CAD	0.0%
2021	- CAD	-100.0%
2020	5438.00 CAD	-69.97%
2019	18.1 Thousand CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	100.0%
2014	-75.15 Thousand CAD	-1977.36%
2013	-3618.00 CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%
2005	- CAD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	-7471.00 CAD	0.0%
2024 Q2	-4061.00 CAD	100.0%
2023 FY	- CAD	0.0%
2023 Q3	- CAD	0.0%
2023 Q1	- CAD	0.0%
2023 Q4	- CAD	0.0%
2023 Q2	- CAD	0.0%
2022 Q3	- CAD	0.0%
2022 FY	- CAD	0.0%
2022 Q1	- CAD	0.0%
2022 Q2	- CAD	0.0%
2022 Q4	- CAD	0.0%
2021 Q1	5438.00 CAD	0.0%
2021 Q2	5438.00 CAD	0.0%
2021 Q3	5438.00 CAD	0.0%
2021 Q4	- CAD	-100.0%
2021 FY	- CAD	-100.0%
2020 Q1	14.45 Thousand CAD	-20.16%
2020 Q4	5438.00 CAD	-54.71%
2020 FY	5438.00 CAD	-69.97%
2020 Q3	12 Thousand CAD	-9.43%
2020 Q2	13.25 Thousand CAD	-8.3%
2019 Q3	-34.89 Thousand CAD	-20.03%
2019 Q4	18.1 Thousand CAD	151.89%
2019 FY	18.1 Thousand CAD	0.0%
2019 Q1	-12.44 Thousand CAD	81.62%
2019 Q2	-29.07 Thousand CAD	-133.69%
2018 Q4	-67.66 Thousand CAD	-21.75%
2018 Q3	-55.57 Thousand CAD	-125.22%
2018 Q2	-24.67 Thousand CAD	59.96%
2018 Q1	-61.63 Thousand CAD	-15.31%
2018 FY	- CAD	0.0%
2017 Q1	-41.99 Thousand CAD	11.93%
2017 Q4	-53.44 Thousand CAD	0.0%
2017 Q3	- CAD	100.0%
2017 FY	- CAD	0.0%
2017 Q2	-47.31 Thousand CAD	-12.65%
2016 Q2	-32.7 Thousand CAD	-38.85%
2016 FY	- CAD	0.0%
2016 Q3	-37.55 Thousand CAD	-14.84%
2016 Q1	-23.55 Thousand CAD	-11.51%
2016 Q4	-47.68 Thousand CAD	-26.98%
2015 Q1	-14.39 Thousand CAD	80.84%
2015 Q4	-21.12 Thousand CAD	-85.62%
2015 Q3	-11.37 Thousand CAD	-179.97%
2015 Q2	-4064.00 CAD	71.77%
2015 FY	- CAD	100.0%
2014 Q3	-11.98 Thousand CAD	-146.63%
2014 Q1	- CAD	100.0%
2014 FY	-75.15 Thousand CAD	-1977.36%
2014 Q4	-75.15 Thousand CAD	-527.06%
2014 Q2	-4860.00 CAD	0.0%
2013 Q1	-10.64 Thousand CAD	0.0%
2013 Q2	-6083.00 CAD	42.86%
2013 Q3	-7730.00 CAD	-27.08%
2013 FY	-3618.00 CAD	0.0%
2013 Q4	-3618.00 CAD	53.2%
2012 Q4	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q3	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q1	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 FY	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q4	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q3	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 Q2	- CAD	0.0%
2007 Q1	- CAD	0.0%
2006 Q3	- CAD	0.0%
2006 Q4	- CAD	0.0%
2006 FY	- CAD	0.0%
2006 Q2	- CAD	0.0%
2005 FY	- CAD	0.0%

Peer Inventory Comparison of Nova Mentis Life Science Corp.

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	100.448%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	167.65%
SQZ Biotechnologies Company	- USD	Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	100.411%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	100.324%
Mesoblast Limited	1.00 USD	697100.0%
Propanc Biopharma, Inc.	- USD	Infinity%
Genus plc	89.4 Million USD	100.008%
VioQuest Pharmaceuticals, Inc.	- USD	Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	92.633%
Marizyme, Inc.	24.85 Thousand USD	128.043%
ContraFect Corporation	- USD	Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	143.563%
PsyBio Therapeutics Corp.	- USD	Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	Infinity%
Intellipharmaceutics International Inc.	1.00 USD	697100.0%
AXIM Biotechnologies, Inc.	- USD	Infinity%
MultiCell Technologies, Inc.	- USD	Infinity%
Accustem Sciences Inc.	- USD	Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	100.889%
EV Biologics, Inc.	- USD	Infinity%
Q BioMed Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	100.407%
Neon Bloom, Inc.	7938.00 USD	187.805%
Mosaic ImmunoEngineering Inc.	- USD	Infinity%
Biomind Labs Inc.	- USD	Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Pharming Group N.V.	56.76 Million USD	100.012%
Oncotelic Therapeutics, Inc.	- USD	Infinity%
Skye Bioscience, Inc.	- USD	Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	130.876%
THC Farmaceuticals, Inc.	- USD	Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	100.511%
IMV Inc.	2.00 USD	348600.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	158.083%
Curative Biotechnology, Inc.	-115.62 Thousand USD	93.972%
GB Sciences, Inc.	- USD	Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	107.709%
HST Global, Inc.	- USD	Infinity%
CSL Limited	5.96 Billion USD	100.0%
Halberd Corporation	- USD	Infinity%
Enzolytics Inc.	- USD	Infinity%
Resverlogix Corp.	2.37 Million USD	100.294%
Affymax, Inc.	- USD	Infinity%
SYBLEU INC	- USD	Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	103.326%
argenx SE	310.55 Million USD	100.002%
MetaStat, Inc.	- USD	Infinity%
Northwest Biotherapeutics, Inc.	- USD	Infinity%
Enzon Pharmaceuticals, Inc.	- USD	Infinity%
Arno Therapeutics, Inc.	- USD	Infinity%
RespireRx Pharmaceuticals Inc.	- USD	Infinity%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	- USD	Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	160.503%
Zenith Capital Corp.	3.00 USD	232433.333%
Genscript Biotech Corporation	53.33 Million USD	100.013%
Ember Therapeutics, Inc.	- USD	Infinity%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	113.94%
WPD Pharmaceuticals Inc.	0.25 USD	2788100.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	100.034%
Provectus Biopharmaceuticals, Inc.	- USD	Infinity%
Adynxx, Inc.	- USD	Infinity%
Helix BioMedix, Inc.	- USD	Infinity%
GlobeStar Therapeutics Corporation	- USD	Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	100.054%
Cotinga Pharmaceuticals Inc.	0.98 USD	711324.49%
BioStem Technologies, Inc.	658.67 Thousand USD	101.058%
ONE Bio Corp.	4.5 Million USD	100.155%
Reve Technologies, Inc.	- USD	Infinity%
Burzynski Research Institute, Inc.	- USD	Infinity%
Wesana Health Holdings Inc.	1.00 USD	697100.0%
Agentix Corp.	- USD	Infinity%
LadRx Corporation	- USD	Infinity%
Cell Source, Inc.	- USD	Infinity%
ProtoKinetix, Incorporated	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
NovAccess Global Inc.	- USD	Infinity%
Endonovo Therapeutics, Inc.	- USD	Infinity%
Itoco Inc.	- USD	Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	66.281%
Pathfinder Cell Therapy, Inc.	- USD	Infinity%
Kadimastem Ltd	- USD	Infinity%
Oncology Pharma Inc.	- USD	Infinity%
Institute of Biomedical Research Corp.	- USD	Infinity%
CytoDyn Inc.	- USD	Infinity%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	- USD	Infinity%
Mobile Lads Corp.	- USD	Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	-79922.962%
Qrons Inc.	- USD	Infinity%
Alseres Pharmaceuticals, Inc.	- USD	Infinity%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	- USD	Infinity%
Rebus Holdings, Inc.	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	Infinity%
International Stem Cell Corporation	1.26 Million USD	100.552%
Bioxytran, Inc.	- USD	Infinity%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	15 Million USD	100.046%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	- USD	Infinity%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	- USD	Infinity%
Adhera Therapeutics, Inc.	- USD	Infinity%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	- USD	Infinity%
Innovation Pharmaceuticals Inc.	- USD	Infinity%
Neutra Corp.	- USD	Infinity%
Windtree Therapeutics, Inc.	- USD	Infinity%
PureTech Health plc	- USD	Infinity%
Coeptis Therapeutics, Inc.	- USD	Infinity%
IXICO plc	1.00 USD	697100.0%
IntelGenx Technologies Corp.	71 Thousand USD	109.817%
Gelesis Holdings, Inc.	6.86 Million USD	100.102%
CSL Limited	5.96 Billion USD	100.0%
Cellectis S.A.	1.00 USD	697100.0%

Global Stocks Search

Nova Mentis Life Science Corp. (NMLSF)

Inventory Summary of Nova Mentis Life Science Corp.

Annual Inventory Chart of Nova Mentis Life Science Corp. (2023 - 2005)

Historical Annual Inventory of Nova Mentis Life Science Corp. (2023 - 2005)

Peer Inventory Comparison of Nova Mentis Life Science Corp.